replimune / Home -

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://replimune.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	Home -
Description	Our Replimune is pioneering the development of a novel class of tumor-directed oncolytic immunotherapies designed to deliver transformational results for difficult-to-treat
Keywords	N/A

Server Information

WebSite	replimune.com
Host IP	75.126.14.26
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

replimune.com Valuation

US$16,473,983

Last updated: 2023-04-30 08:09:01

replimune.com has Semrush global rank of 642,486. replimune.com has an estimated worth of US$ 16,473,983, based on its estimated Ads revenue. replimune.com receives approximately 1,900,845 unique visitors each day. Its web server is located in United States, with IP address 75.126.14.26. According to SiteAdvisor, replimune.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$16,473,983
Daily Ads Revenue	US$15,207
Monthly Ads Revenue	US$456,203
Yearly Ads Revenue	US$5,474,432
Daily Unique Visitors	126,723
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
replimune.com.	A	299	IP: 75.126.14.26
replimune.com.	NS	86400	NS Record: paul.ns.cloudflare.com.
replimune.com.	NS	86400	NS Record: lila.ns.cloudflare.com.
replimune.com.	MX	300	MX Record: 5 d214216.a.ess.uk.barracudanetworks.com.
replimune.com.	MX	300	MX Record: 10 d214216.b.ess.uk.barracudanetworks.com.
replimune.com.	TXT	300	TXT Record: MS=ms86885200
replimune.com.	TXT	300	TXT Record: ykGOGeTIIF2p4AfWZ1EBWNu/DhpRbAkUC9kJEOB6Nhucbk0RrLeBhZMIoQJjJ1U2Hv7GZHTfaA29SRmlNg7BlQ==
replimune.com.	TXT	300	TXT Record: mjdiuh7cen74iq3bri7505f2vd
replimune.com.	TXT	300	TXT Record: apple-domain-verification=6Ghz50UgWbFJXRQL
replimune.com.	TXT	300	TXT Record: google-site-verification=7IliS0TTNKLMv7M312eolzUY9t7QnKh1awPO5b_6PVM
replimune.com.	TXT	300	TXT Record: v=spf1 mx include:spf.ess.uk.barracudanetworks.com include:spf.protection.outlook.com include:_spf.timwimlim-d5183.swp23.com include:_spf.psm.knowbe4.com ~all
replimune.com.	TXT	300	TXT Record: google-site-verification=RYbgVXrcGsS6JyJeJKuejaKCAtm81HpwKb_LSUdDZA0
replimune.com.	TXT	300	TXT Record: MS=ms90814845
replimune.com.	TXT	300	TXT Record: ciscocidomainverification=24e887fedb2c3ee975c3de7ec950b1c0d9bd48353f4af8d98f8fa675d293fed0

HtmlToTextCheckTime:2023-04-30 08:09:01

Skip to primary navigation Skip to primary sidebar Skip to footer Our Science Cancer involves a failure of the immune system in one of two ways: 1) the immune system is unable to recognize the tumor as foreign, and/or 2) the immune response is disabled or shut down by the tumor. Replimune is pioneering a novel class of tumor-directed oncolytic immunotherapies (TDOI) designed to kill the tumor locally, alter the tumor microenvironment, and ignite a powerful patient-specific immune response. These transformational new therapies are being developed to be tolerable and treat difficult-to-treat cancers. Learn more Ongoing Clinical Trials Replimune has multiple ongoing clinical programs evaluating the safety and effectiveness of our investigational therapies in a range of solid tumor cancers, both when given as a single agent and in combination with other immunotherapies. sidebar sidebar-alt Footer © 2021 Replimune Group Inc. | 500 Unicorn Park Dr, 3rd Floor, Woburn, MA 01801 | Stay

HTTP Headers

HTTP/1.1 301 Moved Permanently
Connection: Keep-Alive
Keep-Alive: timeout=5, max=100
content-type: text/html; charset=UTF-8
x-redirect-by: WordPress
location: https://replimune.com/
date: Sat, 23 Oct 2021 03:31:38 GMT
server: LiteSpeed

HTTP/2 200 
content-type: text/html; charset=UTF-8
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
date: Sat, 23 Oct 2021 03:31:39 GMT
server: LiteSpeed
alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"

replimune.com Whois Information

Domain Name: REPLIMUNE.COM
Registry Domain ID: 1911039829_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2021-02-17T05:43:10Z
Creation Date: 2015-03-18T13:31:13Z
Registry Expiry Date: 2022-03-18T13:31:13Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: ok https://icann.org/epp#ok
Name Server: LILA.NS.CLOUDFLARE.COM
Name Server: PAUL.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T15:40:56Z <<<

replimune.com valuation and analysis